13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001839435-25-000002
Total Value
$607.7M
Positions
33
Other Managers
0
Confidential Omitted
No
Holdings (33)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 3,006,980 | $96.0M | 15.79% |
| 2 | ARRIVENT BIOPHARMA INC | AVBP | 2,059,387 | $54.9M | 9.03% |
| 3 | DIANTHUS THERAPEUTICS INC | DNTH | 2,110,167 | $46.0M | 7.57% |
| 4 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,993,052 | $33.4M | 5.49% |
| 5 | VERONA PHARMA PLC | 925050106 | 571,264 | $26.5M | 4.37% |
| 6 | NUVATION BIO INC | NUVB | 9,202,907 | $24.5M | 4.03% |
| 7 | INSMED INC | INSM | 332,000 | $22.9M | 3.77% |
| 8 | COGENT BIOSCIENCES INC | COGT | 2,763,000 | $21.6M | 3.55% |
| 9 | SCHOLAR ROCK HLDG CORP | SRRK | 488,000 | $21.1M | 3.47% |
| 10 | MIND MEDICINE MINDMED INC | 60255C885 | 3,018,000 | $21.0M | 3.46% |
| 11 | OCULAR THERAPEUTIX INC | OCUL | 2,425,000 | $20.7M | 3.41% |
| 12 | TAYSHA GENE THERAPIES INC | TSHA | 10,450,000 | $18.1M | 2.97% |
| 13 | INSMED INC | INSM | 250,000 | $17.3M | 2.84% |
| 14 | VIRIDIAN THERAPEUTICS INC | VRDN | 870,000 | $16.7M | 2.74% |
| 15 | GOSSAMER BIO INC | GOSS | 18,350,000 | $16.6M | 2.73% |
| 16 | DYNE THERAPEUTICS INC | DYN | 668,000 | $15.7M | 2.59% |
| 17 | PHARVARIS N V | PHVS | 778,000 | $14.9M | 2.45% |
| 18 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 1,115,000 | $13.2M | 2.17% |
| 19 | MERUS N V | N5749R100 | 308,000 | $13.0M | 2.13% |
| 20 | ERASCA INC | ERAS | 5,136,795 | $12.9M | 2.12% |
| 21 | BRIDGEBIO PHARMA INC | BBIO | 441,600 | $12.1M | 1.99% |
| 22 | SYNDAX PHARMACEUTICALS INC | SNDX | 904,000 | $12.0M | 1.97% |
| 23 | KALVISTA PHARMACEUTICALS INC | KALV | 1,370,000 | $11.6M | 1.91% |
| 24 | UNICYCIVE THERAPEUTICS INC | UNCY | 10,000,000 | $7.9M | 1.31% |
| 25 | REGULUS THERAPEUTICS INC | 75915K309 | 4,848,802 | $7.7M | 1.26% |
| 26 | PERSPECTIVE THERAPEUTICS INC | CATX | 2,304,752 | $7.4M | 1.21% |
| 27 | NEUROGENE INC | NGNE | 303,000 | $6.9M | 1.14% |
| 28 | ALLOVIR INC | 019818202 | 11,215,000 | $4.7M | 0.78% |
| 29 | ATYR PHARMA INC | ATYR | 900,000 | $3.3M | 0.54% |
| 30 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.43% |
| 31 | CENTESSA PHARMACEUTICALS PLC | CNTA | 152,000 | $2.5M | 0.42% |
| 32 | MERSANA THERAPEUTICS INC | 59045L106 | 992,000 | $1.4M | 0.23% |
| 33 | NUVATION BIO INC | NUVB | 312,336 | $830,814 | 0.14% |